FdaApplication

ANDA 206226

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRISING PHARMA HOLDING INC
application_typeANDA
approval_date2019-03-26

Products (2)

ProductActive ingredientStrengthDosage form
ENTECAVIRENTECAVIR1MGTABLET;ORAL
ENTECAVIRENTECAVIR0.5MGTABLET;ORAL

2 products